SNDK
Sandisk Corporation
SNDK has the edge over XPER overall, supported by stronger fundamentals and stronger modeled upside.
XPER
Xperi Inc.
XPER has lower modeled downside risk, despite its lower overall score.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
XPER Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Healthy |
XPER's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
XPER PE Valuation
XPER has no meaningful PE right now: it lost money over the past year.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
XPER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for XPER, with profitability improving. However, they disagree widely on these estimates.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over XPER in the latest year-over-year earnings comparison.
XPER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.07 | — |
| Q3 2026 | -$0.68 | -525% |
| Q2 2026 | -$0.70 | -$0.62 |
| Q1 2026 | -$0.99 | -$0.56 |
| Q4 2025 | -$1.23 | -$0.92 |
| Q3 2025 | $0.16 | +$2.05 |
| Q2 2025 | -$0.08 | +$2.40 |
| Q1 2025 | -$0.43 | +$2.28 |
| Q4 2024 | -$0.31 | +$2.87 |
XPER has swung to a loss: it lost $0.68 per share over the past year, after a profit the year before.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over XPER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over XPER on profitability, with a higher operating margin.
XPER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $114M | +2.1% |
| Q2 2026 | $114.5M | +8.1% |
| Q1 2026 | $114.2M | +0.2% |
| Q4 2025 | $116.5M | -4.8% |
| Q3 2025 | $111.6M | -16% |
| Q2 2025 | $105.9M | -11% |
| Q1 2025 | $114M | -4% |
| Q4 2024 | $122.4M | -11% |
XPER's revenue fell from its 2020 peak and has held roughly level since: $114M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +2.8 points |
| Q2 2026 | 2.5% | +13 points |
| Q1 2026 | 1.9% | +16 points |
| Q4 2025 | -13% | -1 points |
| Q3 2025 | -1.2% | +13 points |
| Q2 2025 | -11% | +7.8 points |
| Q1 2025 | -14% | +13 points |
| Q4 2024 | -12% | +10 points |
XPER's operating margin was 1.6% last quarter, up 2.8 points from the same quarter a year ago.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over XPER on cash generation, producing positive trailing cash flow while its opponent burns cash.
XPER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | -51% |
| Q2 2026 | $14.1M | +47% |
| Q1 2026 | -$19.1M | +$4.2M |
| Q4 2025 | $1.2M | +$1.7M |
| Q3 2025 | $6.7M | +$12.4M |
| Q2 2025 | $9.5M | +$12.1M |
| Q1 2025 | -$23.3M | +$28.3M |
| Q4 2024 | -$510K | -103% |
XPER's free cash flow was −$633,000 over the past year, against −$8M the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over XPER on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
XPER Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +360K shares |
| 1 year | +5.4% | +2.5M shares |
| 3 years | +13% | +5.5M shares |
| 5 years | +17% | +7.1M shares |
| Available history | -2.8% | -1.4M shares |
XPER has 49M diluted shares, up 5.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | $10M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $31.9M |
| Q2 2021 | $11M |
| Q1 2021 | $32.4M |
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
XPER Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -12.5x | Net Cash |
| Q3 2025 | -8.5x | Net Cash |
| Q3 2021 | 2.9x | Moderate |
| Q2 2021 | 2.5x | Moderate |
| Q1 2021 | 2.6x | Moderate |
XPER has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
XPER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 30.8 | Neutral |
XPER's weekly RSI is 50 (neutral) and its Stochastic is 31 (neutral).
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
XPER PE vs Technology Sector
| Metric | XPER | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
XPER has no meaningful PE right now: it lost money over the past year.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
XPER has stronger trend alignment. SNDK is above 0 of 3 weekly averages versus XPER above 1 of 5.
XPER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.44 | 13% above |
| 20 week MA | $6.27 | 1.9% below |
| 50 week MA | $6.37 | 3.5% below |
| 100 week MA | $6.94 | 11% below |
| 200 week MA | $8.51 | 28% below |
XPER has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 28% below its 200-week average.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over XPER on returns for 2026, with the stronger performance.
XPER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.8 | $8.35 | -44% |
| 2023 | $8.35 | $11.0 | +32% |
| 2024 | $11.0 | $10.1 | -8.1% |
| 2025 | $10.1 | $5.93 | -41% |
| 2026 YTD | $5.93 | $6.15 | +3.7% |
XPER has finished lower in three of the last four years. It's up 3.7% so far in 2026.